Mirae Asset Global ETFs Holdings’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$392K Buy
24,640
+758
+3% +$16.5K ﹤0.01% 2008
2025
Q4
$627K Sell
23,882
-456
-2% -$11.8K ﹤0.01% 1779
2025
Q3
$550K Sell
24,338
-2,149
-8% -$44.3K ﹤0.01% 1827
2025
Q2
$527K Sell
26,487
-25,765
-49% -$502K ﹤0.01% 1794
2025
Q1
$883K Sell
52,252
-1,161
-2% -$19.8K ﹤0.01% 1563
2024
Q4
$987K Sell
53,413
-2,800
-5% -$54.7K ﹤0.01% 1546
2024
Q3
$1.22M Sell
56,213
-6,866
-11% -$154K ﹤0.01% 1433
2024
Q2
$1.24M Buy
+63,079
New +$1.32M ﹤0.01% 1348

Other funds holding FLGT

Mirae Asset Global ETFs Holdings's FLGT Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Fulgent Genetics (FLGT) stake by 3.2% in Q1 2026, buying an estimated $16.5K and bringing the position to 24,640 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #2008.

Mirae Asset Global ETFs Holdings first reported a position in FLGT in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.24M in Q2 2024. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 24,640 shares of Fulgent Genetics worth $392K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 758 Fulgent Genetics shares in Q1 2026, an estimated $16.5K.
  • Fulgent Genetics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2008 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Fulgent Genetics in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Fulgent Genetics position peaked at $1.24M in Q2 2024.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.